ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Cardiovascular"

  • Abstract Number: 1180 • ACR Convergence 2020

    External Validation of a Multi-biomarker-Based Cardiovascular Disease Risk Prediction Score for Rheumatoid Arthritis Patients

    Jeffrey R Curtis1, Eric Sasso2, Elena Hitraya2, Cheryl Chin3, Richard Bamford3, Rotem Ben-Shachar3, Alexander Gutin3, Darl Flake3, Brent Mabey3 and Jerry Lanchbury3, 1Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL, 2Myriad Autoimmune, South San Francisco, CA, 3Myriad Genetics, Inc., Salt Lake City, UT

    Background/Purpose: A novel score for predicting 3-year risk for CVD events in RA patients combines age, four traditional CVD risk factors (diabetes, hypertension, smoking, history…
  • Abstract Number: 1331 • ACR Convergence 2020

    Carotid Ultrasound Findings in Psoriatic Arthritis: A Case-control Study

    Dionicio Ángel Galarza-Delgado1, José Ramón Azpiri López2, Iris Jazmín Colunga Pedraza3, Diana Elsa Flores Alvarado4, Octavio Ilizaliturri Guerra4, Paola Fernanda Frausto Lerma3, Itzel Corina Zárate Salinas2, Alejandra Pérez Villar3, Mayra Alejandra Reyes Soto3, Salvador Lugo Pérez2 and Andrea Cecilia Garza Acosta5, 1Rheumatology Service, Hospital Universitario “Dr. José Eleuterio González”, Universidad Autónoma Nuevo León, Monterrey, Nuevo Leon, Mexico, 2Cardiology Service, Hospital Universitario “Dr. José Eleuterio González”, Universidad Autónoma Nuevo León, Monterrey, Mexico, 3Rheumatology service, Hospital Universitario “Dr. José Eleuterio González”, Universidad Autónoma Nuevo León, Monterrey, Mexico, 4Rheumatology Service, Hospital Universitario “Dr. José Eleuterio González, Universidad Autónoma Nuevo León, Monterrey, Nuevo Leon, Mexico, 5Radiology Service, Hospital Universitario “Dr. José Eleuterio González, Universidad Autónoma Nuevo León, Monterrey, Nuevo Leon, Mexico

    Background/Purpose: Patients with psoriatic arthritis (PsA) have an increased risk of cardiovascular disease (CVD). The carotid ultrasound, which measures both carotid intima-media thickness (cIMT) and…
  • Abstract Number: 1692 • ACR Convergence 2020

    Poor Physical Activity Levels and Cardiorespiratory Fitness Among Patients with Childhood-Onset Takayasu Arteritis in Remission

    Camilla Astley1, Saulo Gil2, Gleice Clemente3, Maria Teresa Terreri4, Lucia Campos5, Nadia Aikawa5, Ana Lucia de-Sá Pinto2, Rosa Pereira5, Hamilton Roschel2 and Bruno Gualano2, 1University of Sao Paulo, Sao Paulo, Sao Paulo, Brazil, 2University of Sao Paulo, Sao paulo, Brazil, 3Federal University of Sao Paulo, Sao Paulo, Brazil, 4Federal University of São Paulo, São Paulo, Brazil, 5Hospital das Clínicas, Faculdade de Medicina da Universidade de Sao Paulo (HCFMUSP), Sao Paulo, Sao Paulo, Brazil

    Background/Purpose: Childhood-onset Takayasu Arteritis (c-TA) is a rare, granulomatous, chronic large-vessel vasculitis that involves mostly the aorta and its major branches with a high mortality…
  • Abstract Number: 0548 • ACR Convergence 2020

    Incidence of First Cardiovascular Event in Spanish Patients with Chronic Inflammatory Rheumatic Diseases. Prospective Data After Five Years of Follow Up

    Maria Auxiliadora Martin-Martinez1, Santos Castañeda2, Fernando Sanchez-Alonso3, Carmen García-Gómez4, Carlos González_Juanatey5, M. Ángeles Belmonte-López6, Jesus Tornero-Molina7, José Santos-Rey8, Carmen Olga Sánchez-González9, Estefania Moreno10, Maria del puerto Moreno-Gil11, Tatiana Cobo-Ibañez12, Jose Antonio Pinto-Tasende13, Jesús Babío-Herráez14, Gema Bonilla15, Antonio Juan-Mas16, Francisco Manero-Ruiz17, Montserrat Romera-Baurés18, Javier Bachiller-Corral19, Eugenio Chamizo-Carmona20, Javier Calvo-Catalán21, Raimon Sanmartí22, Celia Erausquin-Arruabarrena23, Rosario Garcia-Vicuña24, Carmen Barbadillo25, Sergio Ros-Expósito26, Ana Isabel Turrión27, M José González-Fernández28, Jose Miguel Senabre29, Silvia Martínez-Pardo30, Ana Ruibal-Escribano31, Emilio Giner-Serret32, Elisabet Berzosa-Sola33, Julia Martínez-Barrio34, Encarnación Pagán35, M Enriqueta- Peiró36, Sagrario Bustabad-Reyes37, Alba Erra-Durán38, Beatriz González Álvarez39, Ana Cruz Valenciano40, Javier Rivera-Redondo41, Manuel Moreno Ramos42, Sergio Rodriguez Montero43, Mercedes Morcillo-Valle44, Maria Teresa Navío45, Maria Galindo-Izquierdo46, Manuel Riera-Soler47, Jordi Fiter48, Javier Llorca49 and Miguel Ángel González-Gay50, 1Spanish Society of Rheumatology, Madrid, Spain, 2Princesa University Hospital, Universidad Autónoma, Madrid, Madrid, Spain, 3Biobadaser, Research Unit, Sociedad Española de Reumatología, Madrid, Spain, 4Consorci Sanitari de Terrassa, Barcelona, Spain, 5Hospital Lucus Augusti, Lugo, Spain, 6Hospital Regional Universitario Carlos Haya, Malaga, Spain, 7University Hospital of Guadalajara. Spain, Madrid, Madrid, Spain, 8Hospital Virgen de la Salud, Toledo, Spain, 9Hospital Sureste, Madrid, Spain, 10Universitario Vall D'hebron, Barcelona, Spain, 11Complejo Hospitalario de Cáceres, Caceres, Spain, 12Hospital Infanta Sofia, Madrid, Spain, 13CHUAC, A Coruña, Spain, 14Hospital de Cabueñes, Gijón, Spain, 15Rheumatology, La Paz University Hospital-IdiPAZ, Madrid, Spain, 16Hospital Sont Llatzer, Palma de Mallorca, Spain, 17Hospital Universitario Miguel Servet, Zaragoza, Spain, 18Hospital Universitario de Bellvitge, Barcelona, Spain, 19Rheumatology, Hospital Universitario Ramón y Cajal, Madrid, Spain, 20Hospital de Merida, Badajoz, Spain, 21Hospital General Universitario Valencia, Valencia, Spain, 22Hospital Universitari Clínic de Barcelona, Barcelona, Catalonia, Spain, 23Hospital de Gran Canaria Dr. Negrín, Gran Canaria, Spain, 24Hospital Universitario de la Princesa, IIS-Princesa, UAM, Madrid, Madrid, Spain, 25Hospital Universitario Puerta de Hierro, Madrid, Spain, 26Hospital Viladecans, Barcelona, Spain, 27Hospital Universitario de Salamanca, Salamanca, Spain, 28Hospital Dexeus, Barcelona, Spain, 29Hospital de Marina Baixa, Alicante, Spain, 30H. Mutua de Terrassa, Barcelona, Catalonia, Spain, 31Hospital Alfredo Espinosa, Urduliz, Pais Vasco, Spain, 32Hospital Obispo Polanco, Teruel, Spain, 33Hospital del Elda, Alicante, Spain, 34Hospital General Universitario Gregorio Marañón, Madrid, 35Hospital Los Arcos, Murcia, Spain, 36Hospital Marques de Valdecilla, Santander, Spain, 37Hospital Universitario Canarias, Tenerife, Spain, 38Hospital San Rafael, Barcelona, Spain, 39Hospital Universitario Nuestra Señora de la Candelaria, Santa Cruz de Tenerife, Spain, 40Hospital Severo Ochoa, Madrid, Spain, 41Instituto Provincial de Rehabilitación, Madrid, Spain, 42Hospital Virgen de la Arrixaca, Murcia, Spain, 43H. Virgen de Valme, Sevilla, Spain, 44Hospital El Escorial, Madrid, Spain, 45Hospital Infanta Leonor, Madrid, Spain, 46Hospital Universitario 12 de Octubre, Madrid, Spain, 47Hospital dos de Maig, Barcelona, Spain, 48Hospital Universitario Son Dureta, Palma de Mallorca, Spain, 49School of Medicine, University of Cantabria, and CIBER Epidemiología y Salud Pública (CIBERESP), Santander, Spain, 50Hospital Universitario Marques de Valdecilla, Santander, Cantabria, Spain

    Background/Purpose: To determine the incidence and risk factors implicated in the development of first cardiovascular (CV) event (CVE) in patients with chronic inflammatory rheumatic diseases…
  • Abstract Number: 1182 • ACR Convergence 2020

    Increased Prevalence of Carotid Atherosclerosis in Postmenopausal Women with Rheumatoid Arthritis: A Case Control Study

    Dionicio Ángel Galarza-Delgado1, José Ramón Azpiri López2, Iris Jazmín Colunga Pedraza3, Mayra Alejandra Reyes Soto3, Alejandra Pérez Villar3, Itzel Corina Zárate Salinas2, Paola Fernanda Frausto Lerma3 and Salvador Lugo Pérez2, 1Rheumatology Service, Hospital Universitario “Dr. José Eleuterio González”, Universidad Autónoma Nuevo León, Monterrey, Nuevo Leon, Mexico, 2Cardiology Service, Hospital Universitario “Dr. José Eleuterio González”, Universidad Autónoma Nuevo León, Monterrey, Mexico, 3Rheumatology service, Hospital Universitario “Dr. José Eleuterio González”, Universidad Autónoma Nuevo León, Monterrey, Mexico

    Background/Purpose: Cardiovascular disease (CVD) is the primary cause of mortality in women in developed countries. CVD risk rises with age, yet for women there is…
  • Abstract Number: 1332 • ACR Convergence 2020

    Identifying the as Patient at Risk: Is Aortic Root Diameter Associated with HLA-B27?

    Milad Baniaamam1, Sjoerd C. Heslinga2, M. Louis Handoko3, Thelma C. Konings3, Otto Kamp3, Vokko P. van Halm4, J. Christiaan van Denderen1, Irene van der Horst-Bruinsma2 and Mike Nurmohamed5, 1Reade, Amsterdam, Netherlands, 2Department of Rheumatology, Amsterdam UMC, location VU University Medical Centre, Amsterdam, Netherlands, 3Department of Cardiology, Amsterdam UMC, location VU University Medical Centre, Amsterdam, Netherlands, 4Department of Cardiology, Amsterdam UMC, location VU University Medical Centre, Amsterdam, 5Amsterdam Rheumatology and immunology Center, location Reade and Amsterdam UMC, VU medical center, Amsterdam, Netherlands

    Background/Purpose: Ankylosing spondylitis (AS) is an inflammatory joint disease (IJD) associated with cardiac involvement particularly aortic valve regurgitation (AVR).  AVR in AS is caused by…
  • Abstract Number: 1792 • ACR Convergence 2020

    Platelet-bound C4d Is Associated with an Increased Risk of Arterial and Venous Thromboses in SLE

    Yevgeniya Gartshteyn1, Roberta Vezza Alexander2, John Conklin3, Thierry Dervieux4 and Anca Askanase5, 1Columbia University College of Physicians and Surgeons, Glen Rock, NJ, 2Exagen Inc, Vista, CA, 3Exagen Inc., Vista, CA, 4Prometheus Biosciences Inc, San Diego, CA, 5Columbia University College of Physicians and Surgeons, New York, NY

    Background/Purpose: Platelet-bound complement activation products (PC4d), defined as PC4d20 net mean fluorescent intensity [MFI], or a thrombotic risk score that includes PC4d, C3 and anti-phosphatidylserine/prothrombin…
  • Abstract Number: 0558 • ACR Convergence 2020

    Statin Use Pattern in Patients with Inflammatory Joint Disease in a Single Site VA Medical Center

    Lenche Kostadinova1, Sofi Damjanovska2, Angela Gupta3, Ibtissam Gad4, Sameena Syed4, Alyssa Lange5, Corinne Kowal6, Carey Shive7, Christopher Burant4, Brigid Wilson4, David Canaday4, David Zidar8, Donald Anthony9 and Maya Mattar10, 1(1) Department of Medicine, VA Medical Center and VA GRECC, Case Western Reserve University, Cleveland OH, Highland Heights, OH, 2(1) Department of Medicine, VA Medical Center and VA GRECC, Case Western Reserve University, Cleveland OH, Cleveland, OH, 3(1) Department of Medicine, VA Medical Center and VA GRECC, Case Western Reserve University, Cleveland OH, Cleveland, 4(1) Department of Medicine, VA Medical Center and VA GRECC, Case Western Reserve University, Cleveland OH, ohio, 5Case Western Reserve University, Cleveland, 6Case western reserve university/Cleveland VA Medical Center, ohio, 7(2) Department of Pathology, Case Western Reserve University, ohio, 8Case Western Reserve University/Cleveland VA Medical Center, Cleveland, 9Case Western Reserve University/Cleveland VA Medical Center/MetroHealth Medical Center, Cleveland, OH, 10Department of Medicine, VA Medical Center and VA GRECC, Case Western Reserve University, Cleveland OH, Cleveland, OH

    Background/Purpose: Patients with inflammatory joint disease, including rheumatoid arthritis (RA), psoriatic arthritis (PsA) and ankylosing spondylitis (AS) carry increased risk of cardiovascular disease (CVD). Mechanisms…
  • Abstract Number: 1184 • ACR Convergence 2020

    In a Prospective RA Cohort, Higher Baseline Disease Activity Is an Independent Predictor of Decline in Left Ventricular Diastolic Function

    Elizabeth Park1, Kazato Ito2, Christopher Depender1, Jon Giles1 and Joan Bathon1, 1Division of Rheumatology, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, 2Division of Cardiology, Columbia University Vagelos College of Physicians and Surgeons, New York, NY

    Background/Purpose: Rheumatoid Arthritis (RA) patients are at nearly 50% increased risk of heart failure (HF) compared to non-RA patients, despite adjusting for the presence of…
  • Abstract Number: 1333 • ACR Convergence 2020

    Ankylosing Spondylitis Patients at Risk of Developing Aortic Valve Regurgitation, Need for Mandatory Echocardiography?

    Milad Baniaamam1, Sjoerd C. Heslinga2, Laura Boekel1, M. Louis Handoko3, Thelma C. Konings3, Otto Kamp3, Vokko P. van Halm4, J. Christiaan van Denderen1, Irene van der Horst-Bruinsma2 and Mike Nurmohamed5, 1Reade, Amsterdam, Netherlands, 2Department of Rheumatology, Amsterdam UMC, location VU University Medical Centre, Amsterdam, Netherlands, 3Department of Cardiology, Amsterdam UMC, location VU University Medical Centre, Amsterdam, Netherlands, 4Department of Cardiology, Amsterdam UMC, location VU University Medical Centre, Amsterdam, 5Amsterdam Rheumatology and immunology Center, location Reade and Amsterdam UMC, VU medical center, Amsterdam, Netherlands

    Background/Purpose: The overall mortality rate in ankylosing spondylitis (AS) patients is increased by 60–90% compared with the general population. This higher mortality rate is predominately…
  • Abstract Number: 1795 • ACR Convergence 2020

    Intracellular Homocysteine and Homocysteine Metabolites in Systemic Lupus Erythematosus (SLE)

    George Stojan1, Jessica Li1, Amrita Raj2, Maureen Kane3 and Michelle Petri4, 1Johns Hopkins University, BALTIMORE, MD, 2Johns Hopkins University, Baltimore, 3University of Maryland School of Pharmacy, Baltimore, 4Johns Hopkins University School of Medicine, Baltimore

    Background/Purpose: In SLE, homocysteine has been shown to be a potentially modifiable, independent risk factor for stroke and thrombotic events. All previous epidemiological studies used…
  • Abstract Number: 0650 • ACR Convergence 2020

    Risk of Vertebral Fractures at Lateral Chest Radiographies in Patients with Gout

    Marco Ferrández-Jiménez1, Irene Calabuig2, Maria Luisa Peral2, Miguel Gómez-Garberí1 and Mariano Andrés2, 1Universidad Miguel Hernández de Elche, Alicante, Spain, 2Hospital General Universitario de Alicante-ISABIAL and Universidad Miguel Hernández de Elche, Alicante, Spain

    Background/Purpose: Osteoporosis causes significant morbidity and mortality through the development of fragility fractures, including vertebral fractures (VF). Patients with gout may show an increased risk…
  • Abstract Number: 1185 • ACR Convergence 2020

    Performance of the MBDA-based CVD Risk Score in RA Patient Groups of Clinical Interest

    Jeffrey R Curtis1, Fenglong Xie2, Cynthia Crowson3, Eric Sasso4, Elena Hitraya4, Cheryl Chin5, Richard Bamford5, Rotem Ben-Shachar5, Alexander Gutin5, Darl Flake5, Brent Mabey5 and Jerry Lanchbury5, 1Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL, 2University of Alabama at Birmingham, Birmingham, AL, 3Mayo Clinic, Rochester, Minnesota, USA, Rochester, MN, 4Myriad Autoimmune, South San Francisco, CA, 5Myriad Genetics, Inc., Salt Lake City, UT

    Background/Purpose: A novel risk prediction score combines serum biomarkers from the multi-biomarker disease activity (MBDA) test with clinical information to predict 3-year risk for a…
  • Abstract Number: 1393 • ACR Convergence 2020

    Systemic Sclerosis: Subclinical Aterosclerosis and Morbimortality

    Miriam Retuerto1, Jose Luis Rosales2, Maria Martin1, Beatriz Joven1 and Patricia E Carreira1, 1Hospital universitario 12 de octubre, Madrid, Spain, 2Hospiten Rambla, Santa Cruz de Tenerife, Spain

    Background/Purpose: Rheumatic diseases are associated with accelerated atherosclerosis, and an increase in cardiovascular morbidity and mortality. This process is mediated by classic cardiovascular risk factors…
  • Abstract Number: 1821 • ACR Convergence 2020

    Early Assessment of Left Ventricular Assessment Using Speckle Tracking Echocardiography and It´s Relationship with Insulin Resistance in Women with Systemic Lupus Erythematosus

    Pamela Munguía-Realpozo1, Claudia Mendoza-Pinto2, Socorro Méndez-Martínez2, Liliana Pérez-Aquino3, Ivet Etchegaray-Morales1 and Mario Garcia-Carrasco2, 1Facultad de Medicina, Benemérita Universidad Autónoma de Puebla, Puebla, Puebla, Mexico, 2Instituto Mexicano del Seguro Social, Puebla, Puebla, Mexico, 3Facultad de Medicina, Beneméria Universidad Autónoma de Puebla, Puebla, Puebla, Mexico

    Background/Purpose: Systemic lupus erythematosus patients (SLE) have increased cardiovascular risk. Patients with SLE are associated with significant alterations in cardiac structure and function as demonstrated…
  • « Previous Page
  • 1
  • …
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology